2BB score and signals
Summit Therapeutics Inc.’s current 2BB score is 68 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 68 | High |
| Momentum | 45 | Stable |
| Financial strength | 0 | Very Weak |
| Quality | 100 | Very Strong |
| Risk | 39 | Low |
Company facts
| Founded | Aug 4, 2004 |
| Employees | 61 |
| 52-week range | $12.07 – $29.23 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-02-22 | — | -0.3747 | — | $4.05M |
| 2026-10-19 | — | -0.299 | — | $72,858.00 |
| 2026-07-23 | — | -0.2849 | — | $0.00 |
| 2026-04-30 | -0.24 | -0.1801 | $0.00 | $72,114.00 |
Related companies
